High Reported Treatment Satisfaction in People With Type 1 Diabetes Switching to Latest Generation Insulin Pump Regardless of Previous Therapy

Barnard, Katharine; Bromba, Michael; Lange, Mirja de; Halbron, M.; Levy, Brian; Lévy, Marc; Lippmann-Grob, Bernhard; Walshe, K; Ziegler, Ralph

doi:10.1177/1932296814567893

Cited by 15 publications

(16 citation statements)

References 30 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is some consistency regarding the perceived physical outcomes and satisfaction of the above study with the findings of Barnard et al [45]who measured the relationship between satisfaction when transitioning to then current insulin pumps (Animas Vibe CGM-enabled System IV) and personal glycemic control. The most significant contributing factor to treatment satisfaction was when BG levels were consistently <7.00mmol/l (P =.009).…”

Section: Satisfaction With Transition To the Use Of Advanced Technolosupporting

confidence: 59%

“…The 18 studies included in this review consist of 5 qualitative studies [40][41][42][43][44], 5 experimental studies [31][32][33][34][35], 3 observational studies [28][29][30], 4 cross-sectional studies [36][37][38][39] and 1 mixed methods [45]. Five of the studies were smaller samples drawn from parent clinical trials [29,32,38,40,41].…”

Section: Resultsmentioning

confidence: 99%

“…The data suggests that those from higher socioeconomic groups are more likely to have access to and engage with technology in their self-management behaviors [38]. Two studies [29,45] purposefully selected participants with prior adherent behaviors, however one study recruited participants who were less engaged with technology and adherence [32].…”

Section: Data Abstraction and Analysismentioning

confidence: 99%

See 2 more Smart Citations

Human Factors and Data Logging Processes With the Use of Advanced Technology for Adults With Type 1 Diabetes: Systematic Integrative Review (Preprint)

Waite¹,

Martin²,

Franklin³

et al. 2017

Preprint

View full text Add to dashboard Cite

Background: People with T1DM are confronted with self-management tasks and strategies to reduce risks of long-term complications against the risk of hypoglycemic events. The potential of advanced and evolving technology to address these issues involves consideration of psychological and behavioral constructs alongside the usability of devices. Access and uptake of advanced technology is further influenced by economic factors and health care provider capacity to support such interventions. Previous reviews have focused upon either clinical outcomes or descriptively scoped the literature and sometimes synthesize studies on adults with children and young people where human factors are different. Objective:The objective of this review was to describe the relationship between human factors and adherence with technology for data logging processes in adults with T1DM and to explore the factors which influence this association. Methods: A systematic literature review.Results: 18 studies were included in the review following a literature search using the PRISMA guidelines and the quality appraisal process. Six constructs emerged from the data analysis:. The relationship between adherence to data logging and measurable outcomes; Satisfaction with the transition to advanced technology for self-management; Use of advanced technology and time spent on diabetes related activities; Strategies to mediate the complexities of diabetes and the use of advanced technology; Cognition in the wild and Meanings, views and perspectives from the users of technology.There was evidence of increased treatment satisfaction on transition to advanced technology (insulin pump and CGM), the most significant contributing factor was when BG levels were consistently < 7.00mmol/l (P =.009). However, participants spent considerable time on their diabetes self-care. There was evidence that 1 logging of data was positively correlated with increasing age with the use of an app that provided meaningful feedback (regression coefficient = 55.8 recordings/ year; P = 0.009). Furthermore, there were benefits of CGM for older people in mediating complexities and their fears of hypoglycemia with reported significant differences in well-being (P= .009).Qualitative studies within the review aimed to explore the use and uptake of technology within the context of everyday lives. There were 'frustrations' with CGM, CSII, calibration of devices and alarms. In addition, the implications of 'body image' and the way in which 'significant' others impacted on the behavior and attitude of the individual towards technology use. There were wide variations in the normal use of and interaction with technology across a continuum of sociocultural contexts. This has implications for the way in which future technologies are designed. Conclusions:Many of the quantitative studies in the review were limited by small sample sizes. This may make it difficult to generalize findings to other contexts. This is further limited by a sample that was predominantly Caucasian, well-contr...

show abstract

Section: Satisfaction With Transition To the Use Of Advanced Technolosupporting

confidence: 59%

Section: Resultsmentioning

confidence: 99%

Section: Data Abstraction and Analysismentioning

confidence: 99%

See 1 more Smart Citation

Human Factors and Data Logging Processes With the Use of Advanced Technology for Adults With Type 1 Diabetes: Systematic Integrative Review (Preprint)

Waite¹,

Martin²,

Franklin³

et al. 2017

Preprint

View full text Add to dashboard Cite

show abstract

“…The safety profile of this patch has been shown to be similar to currently available injection devices for mealtime insulin [ 11 ]. Current literature indicates that more user-friendly and safe-to-use devices, such as insulin pens or pumps, can lead to improved treatment satisfaction and glycemic control compared with using a syringe for insulin delivery [ 28 , 30 ].…”

Section: Discussionmentioning

confidence: 99%

Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch

et al. 2018

View full text Add to dashboard Cite

IntroductionA basal-bolus insulin regimen is needed to achieve glycated hemoglobin A1c (HbA1c) below 7.0% in people with type 1 (T1D) or type 2 (T2D) diabetes who have significant loss of beta-cell function. Nonadherence to therapy is common and negatively affects the ability to reach treatment goals. We examined patient assessment of a new, wearable mealtime insulin-delivery system (patch) relative to their current mealtime insulin-delivery system (syringe, pen, or pump). The patch is designed to deliver only boluses of fast-acting insulin (no basal insulin), mechanically controlled by the patient.MethodsAdults (n = 101) with T1D or T2D assessed their current mealtime insulin-delivery system and then assessed simulated (no active medication) patch use over a 3-day period. Participants evaluated mealtime insulin-delivery systems using eight measures from five domains (convenience, interference with daily activities, diabetes-related worry, psychological well-being, and overall satisfaction/preference) on the self-administered Insulin Delivery System Rating Questionnaire. User ratings of their current insulin-delivery systems (syringe, pen, pump) were compared with those for the patch by repeated measure analysis of variance and one-sample t tests.ResultsParticipants had significant (p < 0.05) preference for patch over syringe in all eight comparisons, and over pen in five out of eight comparisons, with no significant preference for pen. Although there was a preference for patch over pump in six out of eight comparisons, only one showed a significant preference for patch, and one for pump. Significantly more participants reported that they would like to switch to the patch than continue using a syringe (78% vs 22%) or pen (76% vs 24%) but this difference was not significant for the group using a pump (52% vs 48%).ConclusionsParticipants preferred using the patch over pens and syringes. Its ease of use and discreet method of insulin delivery may contribute to improved patient adherence to mealtime insulin regimens among people currently using injection devices.FundingCalibra Medical

show abstract

“…In this article, we discuss the ITSQ and its use to assess satisfaction with the Animas ® Vibe™ insulin pump, a latest-generation insulin pump (LGIP), which is continuous glucose monitoring (CGM)-enabled, in patients recruited for the Comparing Perception of Insulin Therapies for T1D Patients with the Aim to Improve Quality of Care (CHOICE) study as recently published by Barnard et al 4 …”

mentioning

confidence: 99%

The Insulin Treatment Satisfaction Questionnaire and Assessment of Satisfaction with a Latest-generation Insulin Pump

Bromba

Campbell

Levy³

2015

European Endocrinology

Self Cite

View full text Add to dashboard Cite

Satisfaction with the latest-generation insulin pump (LGIP) was assessed in patients with diabetes mellitus enrolled in the Comparing Perception of Insulin Therapies for T1D Patients with the Aim to Improve Quality of Care (CHOICE) study. The Insulin Treatment Satisfaction Questionnaire (ITSQ), a measure of insulin treatment satisfaction, together with additional questions assessed respondents’ perceptions of glucose control, their satisfaction with major LGIP features and preference for the LGIP versus their previous treatment, was used. The LGIP (Animas® Vibe™) was considered to be a better method for delivering insulin compared with their therapy before switching and was rated high for treatment satisfaction. These findings should be useful to clinicians when considering the possibility of transferring a patient from their existing treatment regimen to a LGIP.

show abstract

High Reported Treatment Satisfaction in People With Type 1 Diabetes Switching to Latest Generation Insulin Pump Regardless of Previous Therapy

Cited by 15 publications

References 30 publications

Human Factors and Data Logging Processes With the Use of Advanced Technology for Adults With Type 1 Diabetes: Systematic Integrative Review (Preprint)

Human Factors and Data Logging Processes With the Use of Advanced Technology for Adults With Type 1 Diabetes: Systematic Integrative Review (Preprint)

Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch

The Insulin Treatment Satisfaction Questionnaire and Assessment of Satisfaction with a Latest-generation Insulin Pump

Contact Info

Product

Resources

About